Tag: biosimilar entry timeline
Learn how the 12-year biologic exclusivity rule under the BPCIA delays biosimilar entry, impacting drug prices and patient access in the US compared to global markets.
Medications
Archives
Recent-posts
Medicaid Generic Drug Policies: How States Are Cutting Prescription Costs
Dec, 29 2025
Mental Health and Medication Non-Adherence: What Actually Works
Dec, 4 2025
9 Alternatives to Levothyroxine
Apr, 7 2025
Alcohol's Impact on Inflammation: What You Need to Know
Mar, 19 2025
Counterfeit Medication Red Flags: What to Watch For
Dec, 1 2025